Obesity represents an established risk factor for breast cancer, and potential biological mechanisms underlying this relationship include insulin resistance and abnormalities in the insulin-like growth factor-1 (IGF-1) axis, sex hormones biosynthesis, subclinical chronic inflammation, and alterations in adipokine pathophysiology [5]. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.